Current Report Filing (8-k)
December 14 2020 - 3:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 14, 2020
NanoVibronix,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
001-36445
|
|
01-0801232
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
525
Executive Blvd., Elmsford, NY 10523
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (914) 233-3004
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common Stock, par
value $0.001 per share
|
|
NAOV
|
|
Nasdaq Capital Market
|
Item
8.01 Other Events.
As
previously disclosed, on August 5, 2020, NanoVibronix, Inc. (the “Company”) was
notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) that it no longer satisfied
the $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the “Rule”).
The Company thereafter presented a compliance plan to the Nasdaq Hearings Panel, which granted the Company an extension through
December 15, 2020 to evidence compliance with the Rule.
On
December 7, 2020, the Company completed a private
placement of its common stock and common-stock equivalents for gross proceeds of approximately $6 million. As
a result of the private placement, the Company believes it satisfies the Rule and all other applicable criteria for continued
listing on The Nasdaq Capital Market as of the date of this filing. The Company awaits Nasdaq’s formal confirmation of the
Company’s compliance with the Rule.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
NANOVIBRONIX, INC.
|
|
|
|
Date: December 14, 2020
|
By:
|
/s/
Stephen Brown
|
|
Name:
|
Stephen Brown
|
|
Title:
|
Chief Financial Officer
|
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From May 2024 to Jun 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jun 2023 to Jun 2024